EXELON 3 MG 28 CAPSULES – What is it, Uses & 2026 Price in Turkey

Clinical Data Review: Comprehensive profile for EXELON 3 MG 28 CAPSULES, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: EXELON 3 MG 28 CAPSULES

Manufacturer: NOVARTIS HEALTH FOOD AND AGRICULTURAL PRODUCTS INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

RIVASTIGMIN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

EXELON 3 MG 28 CAPSULES is formulated with RIVASTIGMIN, a clinically established agent in medical practice.

  • Mechanism of Action: RIVASTIGMIN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to RIVASTIGMIN therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name EXELON 3 MG 28 CAPSULES
Barcode (GTIN) 8699504150308
Generic Name RIVASTIGMIN
License Holder NOVARTIS HEALTH FOOD AND AGRICULTURAL PRODUCTS INDUSTRY AND TRADE INC.
Pharmacy Retail Price 362.03 TL
⚠️ Clinical Safety Warning

Do not administer EXELON 3 MG 28 CAPSULES if the patient has a known hypersensitivity or allergy to RIVASTIGMIN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.


Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via NOVARTIS HEALTH FOOD AND AGRICULTURAL PRODUCTS INDUSTRY AND TRADE INC..

Leave a Comment